NEXT Financial Holdings’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

NEXT Financial Holdings’s Portfolio BHVN Stock Details BHVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$2K	Buy	+41	New	+$1.77K	﹤0.01%	1526

Other funds holding BHVN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

RP Management New York $139M AUM 37.98% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

VMI

VHCP Management II New York $379M AUM 421.62% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

NEXT Financial Holdings's BHVN Position: Q1 2019 in Review

NEXT Financial Holdings opened a new position in Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q1 2019: 41 shares worth $2K. The stake represents ﹤0.01% of the portfolio and ranks #1526 among its holdings.

170 funds tracked by Wall St. Rank hold BHVN as of Q1 2019.

NEXT Financial Holdings held 41 shares of Biohaven Pharmaceutical Holding Company Ltd. worth $2K as of Q1 2019.
Biohaven Pharmaceutical Holding Company Ltd. was a new NEXT Financial Holdings position in Q1 2019.
Biohaven Pharmaceutical Holding Company Ltd. made up ﹤0.01% of NEXT Financial Holdings's portfolio in Q1 2019, its #1526 holding.
170 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q1 2019.

Based on NEXT Financial Holdings's 13F filing for Q1 2019, filed 13 May 2019.